{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:51:00Z","timestamp":1792209060879,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["761104"],"award-info":[{"award-number":["761104"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825828"],"award-info":[{"award-number":["825828"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jconrel.2024.01.016","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T23:06:31Z","timestamp":1705187191000},"page":"611-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Polyethylene glycol (PEG) as a broad applicability marker for LC\u2013MS\/MS-based biodistribution analysis of nanomedicines"],"prefix":"10.1016","volume":"366","author":[{"given":"Astrid","family":"Hyldbakk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terkel","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Even F.","family":"Borgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jconrel.2024.01.016_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae \u2014 the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2024.01.016_bb0015","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.jconrel.2024.01.016_bb0020","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1007\/s13346-022-01159-w","article-title":"Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances","volume":"12","author":"Minnema","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.jconrel.2024.01.016_bb0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40262-014-0227-1","article-title":"Physiologically based pharmacokinetic modelling to inform development of intramuscular long-acting Nanoformulations for HIV","volume":"54","author":"Rajoli","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2015.10.042","article-title":"Stable isotope method to measure drug release from nanomedicines","volume":"220","author":"Skoczen","year":"2015","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2024.01.016_bb0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1021\/acsptsci.0c00011","article-title":"Distinguishing pharmacokinetics of marketed nanomedicine formulations using a stable isotope tracer assay","volume":"3","author":"Skoczen","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2024.01.016_bb0040","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D\u2019Souza","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2024.01.016_bb0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"9\u201310","key":"10.1016\/j.jconrel.2024.01.016_bb0050","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/jssc.201901340","article-title":"Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals","volume":"43","author":"Zhang","year":"2020","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG - a versatile conjugating ligand for drugs and drug delivery systems","volume":"192","author":"Kolate","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.01.016_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine\u2019s most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2024.01.016_bb0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","article-title":"PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution","volume":"9","author":"Hussain","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"31","key":"10.1016\/j.jconrel.2024.01.016_bb0075","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: evidence for immunogenicity of PEG","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2024.01.016_bb0085","doi-asserted-by":"crossref","first-page":"1901223","DOI":"10.1002\/adhm.201901223","article-title":"Size-dependent EPR effect of polymeric nanoparticles on tumor targeting","volume":"9","author":"Kang","year":"2020","journal-title":"Adv. Healthc. Mater."},{"issue":"12","key":"10.1016\/j.jconrel.2024.01.016_bb0090","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118814","article-title":"Dendrimers in the context of nanomedicine","volume":"573","author":"Dias","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"18","key":"10.1016\/j.jconrel.2024.01.016_bb0100","doi-asserted-by":"crossref","first-page":"1907574","DOI":"10.1002\/smll.201907574","article-title":"Polymeric nanoparticles with neglectable protein Corona","volume":"16","author":"Alberg","year":"2020","journal-title":"Small."},{"issue":"7","key":"10.1016\/j.jconrel.2024.01.016_bb0105","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.01.016_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymdegradstab.2020.109388","article-title":"Mass spectrometry investigation into the oxidative degradation of poly(ethylene glycol)","volume":"183","author":"Payne","year":"2021","journal-title":"Polym. Degrad. Stab."},{"issue":"11","key":"10.1016\/j.jconrel.2024.01.016_bb0115","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s13346-022-01150-5","article-title":"Quantification of the actual composition of polymeric nanocapsules: a quality control analysis","volume":"12","author":"Berrecoso","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0120","first-page":"1","article-title":"A comparative biodistribution study of polymeric and lipid-based nanoparticles","volume":"15","author":"\u00c5slund","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2024.01.016_bb0125","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ultrasmedbio.2020.12.026","article-title":"Sonopermeation enhances uptake and therapeutic effect of free and encapsulated Cabazitaxel","volume":"47","author":"Snipstad","year":"2021","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jconrel.2018.11.029","article-title":"Cabazitaxel-loaded poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft","volume":"293","author":"Fusser","year":"2019","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2024.01.016_bb0135","article-title":"LipImageTM 815: novel dye-loaded lipid nanoparticles for long-term and sensitive in vivo near-infrared fluorescence imaging","volume":"18","author":"Jacquart","year":"2013","journal-title":"JBO."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejpb.2021.03.004","article-title":"Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery","volume":"163","author":"Mildner","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"15","key":"10.1016\/j.jconrel.2024.01.016_bb0145","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1021\/ac501507g","article-title":"Quantitative analysis of polyethylene glycol (PEG) and PEGylated proteins in animal tissues by LC\u2013MS\/MS coupled with in-source CID","volume":"86","author":"Gong","year":"2014","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.jconrel.2024.01.016_bb0150","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s13361-011-0180-2","article-title":"Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in Cynomolgus Monkey serum using in-source CID and UPLC\u2013MS\/MS","volume":"22","author":"Li","year":"2011","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.jconrel.2024.01.016_bb0155","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/ac801711u","article-title":"Characterization of poly(ethylene glycol) and PEGylated products by LC\/MS with postcolumn addition of amines","volume":"81","author":"Huang","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2024.01.016_bb0160","author":"Ali"},{"issue":"1","key":"10.1016\/j.jconrel.2024.01.016_bb0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-bioeng-121219-024239","article-title":"Red blood cell hitchhiking: a novel approach for vascular delivery of Nanocarriers","volume":"23","author":"Brenner","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"7","key":"10.1016\/j.jconrel.2024.01.016_bb0170","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/acsnano.9b08693","article-title":"Tumor targeting by \u03b1v\u03b23-integrin-specific lipid nanoparticles occurs via phagocyte hitchhiking","volume":"14","author":"Sofias","year":"2020","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2024.01.016_bb0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/polym12020298","article-title":"The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers."},{"issue":"12","key":"10.1016\/j.jconrel.2024.01.016_bb0180","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:33:19Z","timestamp":1738081999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S0168365924000208"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyethylene glycol (PEG) as a broad applicability marker for LC\u2013MS\/MS-based biodistribution analysis of nanomedicines","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}